Gene expression profile of zebrafish exposed to hypoxia during development

1 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada 2 Cardiovascular Genome Unit, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 Understanding how vertebrates respond to hypoxia can have important clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological genomics 2003-04, Vol.13 (2), p.97-106
Hauptverfasser: Ton, Christopher, Stamatiou, Dimitri, Liew, Choong-Chin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada 2 Cardiovascular Genome Unit, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 Understanding how vertebrates respond to hypoxia can have important clinical implications. Fish have evolved the ability to survive long exposure to low oxygen levels. However, little is known about the specific changes in gene expression that result from hypoxia. In this study we used a zebrafish cDNA microarray to examine the expression of >4,500 genes in zebrafish embryos exposed to 24 h of hypoxia during development. We tested the hypotheses that hypoxia changes gene expression profile of the zebrafish embryos and that these changes can be reverted by reexposure to a normoxic (20.8% O 2 ) environment. Our data were consistent with both of these hypotheses: indicating that zebrafish embryos undergo adaptive changes in gene expression in response to hypoxia. Our study provides a striking genetic portrait of the zebrafish embryos’ adaptive responses to hypoxic stress and demonstrates the utility of the microarray technology as a tool for analyzing complex developmental processes in the zebrafish. Danio rerio ; cDNA microarray
ISSN:1094-8341
1531-2267
DOI:10.1152/physiolgenomics.00128.2002